Your browser doesn't support javascript.
loading
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial.
Highland, Kristin B; Distler, Oliver; Kuwana, Masataka; Allanore, Yannick; Assassi, Shervin; Azuma, Arata; Bourdin, Arnaud; Denton, Christopher P; Distler, Jörg H W; Hoffmann-Vold, Anna Maria; Khanna, Dinesh; Mayes, Maureen D; Raghu, Ganesh; Vonk, Madelon C; Gahlemann, Martina; Clerisme-Beaty, Emmanuelle; Girard, Mannaig; Stowasser, Susanne; Zoz, Donald; Maher, Toby M.
Afiliação
  • Highland KB; Cleveland Clinic, Cleveland, OH, USA.
  • Distler O; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
  • Allanore Y; Department of Rheumatology A, Descartes University, APHP, Cochin Hospital, Paris, France.
  • Assassi S; Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, TX, USA.
  • Azuma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
  • Bourdin A; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France; Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France.
  • Denton CP; University College London Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, London, UK.
  • Distler JHW; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany.
  • Hoffmann-Vold AM; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
  • Khanna D; Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Mayes MD; Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, TX, USA.
  • Raghu G; Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA.
  • Vonk MC; Department of Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Gahlemann M; Boehringer Ingelheim (Schweiz), Basel, Switzerland.
  • Clerisme-Beaty E; Boehringer Ingelheim International, Ingelheim am Rhein, Germany.
  • Girard M; Boehringer Ingelheim Pharma, Biberach, Germany.
  • Stowasser S; Boehringer Ingelheim International, Ingelheim am Rhein, Germany.
  • Zoz D; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.
  • Maher TM; National Heart and Lung Institute, Imperial College London, London, UK; National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: toby.maher@med.usc.edu
Lancet Respir Med ; 9(1): 96-106, 2021 01.
Article em En | MEDLINE | ID: mdl-33412120
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Inibidores de Proteínas Quinases / Indóis / Ácido Micofenólico Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Inibidores de Proteínas Quinases / Indóis / Ácido Micofenólico Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido